News

Exciting Updates from Krystal Biotech: Upcoming Presentations

Exciting Updates from Krystal Biotech: Upcoming Presentations

Krystal Biotech Prepares for Notable Scientific Presentations

Pittsburgh, April 24, 2025 – Krystal Biotech, Inc. (NASDAQ: KRYS) announces its involvement in several prestigious scientific conferences scheduled for May and June. These events will serve as a platform for the Company to present groundbreaking advancements in therapeutic programs targeting the lung, eye, and skin.

The presentations will encompass innovative research findings that are set to impact the future of genetic medicine significantly. Below are the details of the upcoming presentations:

American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

During the upcoming ASGCT Annual Meeting, attendees can expect an invited oral presentation focusing on:

  • Title: HSV-1 as a vector system for targeting respiratory tissues in genetic pulmonary disease
  • Presenter: Trevor Parry, PhD
  • Date and Time: May 17, 2025, at 8:50 AM CT

2025 American Society of Clinical Oncology (ASCO) Annual Meeting

At the flagship ASCO Annual Meeting, Krystal Biotech will participate through a poster presentation discussing:

  • Title: Inhaled KB707, a novel HSV-based immunotherapy, as a monotherapy in patients with advanced solid tumor malignancies affecting the lungs: Efficacy and safety results from a phase 1/2 study
  • Presenter: Wen Wee Ma, MD, Enterprise Vice Chair, Research, Cancer Institute, Cleveland Clinic
  • Date and Time: June 2, 2025, from 1:30 PM to 4:30 PM CT
  • Poster Session or Category: Developmental Therapeutics – Immunotherapy
  • Abstract Number: 2575
  • Poster Bd Number: 222

Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

The ARVO Annual Meeting will showcase Krystal Biotech’s advancements through a poster presentation featuring:

  • Title: Topical application of the HSV-1-based gene therapy vector KB801 results in sustained nerve growth factor expression in wounded murine corneas
  • Presenter: Haley Cartwright, PhD
  • Date and Time: May 5, 2025, from 3:00 PM to 4:45 PM MT
  • Poster Session or Category: 258 – Preclinical Therapeutics
  • Poster Number: B0154

Society for Investigative Dermatology (SID) Annual Meeting

Lastly, the SID Annual Meeting will feature their research on:

  • Title: Expansion of an HSV-1-based gene therapy platform to treat Hailey-Hailey and Darier diseases
  • Presenter: Bruce Nmezi, PhD
  • Date and Time: May 9, 2025, from 4:30 PM to 6:00 PM PT
  • Poster Session or Category: Genetic Disease, Gene Regulation, Gene Therapy & Epigenetics
  • Poster Number: 0554

These scientific conferences will provide valuable insights into Krystal Biotech's ongoing research initiatives. Following each conference, presentation materials, including slides and posters, will be accessible online for interested stakeholders, showcasing the Company’s commitment to transparency and engagement within the scientific community.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) operates as a fully integrated, commercial-stage biotechnology company dedicated to discovering, developing, and commercializing genetic medicines aimed at addressing diseases with significant unmet medical needs. The Company’s first product, VYJUVEK, is recognized as the first-ever redosable gene therapy approved by the FDA, specifically targeting dystrophic epidermolysis bullosa.

With a robust pipeline of investigational genetic treatments across various fields, including respiratory, oncology, dermatology, ophthalmology, and aesthetics, Krystal Biotech is proud to headquarter its operations in Pittsburgh, Pennsylvania. Interested parties can learn more about Krystal Biotech and its innovative approaches by visiting the official website.

Moreover, the Company actively shares updates and insights through its social media channels on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:
Stéphane Paquette, PhD
Krystal Biotech
spaquette@krystalbio.com

Frequently Asked Questions

What is Krystal Biotech known for?

Krystal Biotech is known for its innovative approach to genetic medicine, focusing on the treatment of severe diseases with high unmet medical needs.

What product has Krystal Biotech launched?

Krystal Biotech has launched VYJUVEK, recognized as the first redosable gene therapy approved by the FDA, for the treatment of dystrophic epidermolysis bullosa.

What conferences is Krystal Biotech presenting at?

The Company will present at the ASGCT, ASCO, ARVO, and SID Annual Meetings, showcasing their significant research advancements.

Who will present at the ASGCT Annual Meeting?

Trevor Parry, PhD, will present at the ASGCT Annual Meeting on the use of HSV-1 as a vector for respiratory tissue targeting.

How can stakeholders keep track of Krystal Biotech's updates?

Stakeholders can follow Krystal Biotech on their social media platforms, such as LinkedIn and X, and visit their official website for the latest information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

Updated Category News Views 15

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Continue Reading
California Cash Surplus Raises Investor Eyebrows

Updated Category News Views 44

California's Unexpected Financial Bounty Kicking things off with a real humdinger: California's September cash flow exceeded expectations by a whopping $2.9 billion. That's not chump change, folks. It's like finding an extra twenty in your coat pocket but on a much grander scale. Impressively, the state's General Fund receipts tallied up to $22.9 billion, surpassing the...

Continue Reading
Bechtel's $1M Push for Wyoming's Skilled Trades Future

Updated Category News Views 49

Wyoming's Bid for Skilled Trades Revolution You’d think with all the talk about tech and white-collar jobs, we’ve forgotten the backbone that keeps the world ticking—skilled trades. Turns out, Bechtel hasn’t. The company just tossed a cool million at Wyoming's Laramie County Community College and Western Wyoming College. What’s that doing? It's jumpstarting...

Continue Reading
Unlocking Geothermal's Heat Potential in Europe

Updated Category News Views 54

An Overlooked Powerhouse: Geothermal Heat in Industry These days, it feels like everyone’s got their head in the clouds about renewables—think wind and solar. But under the surface, literally, is geothermal energy, waiting to make a play in Europe’s industrial sector. Project InnerSpace and Future Cleantech Architects are spotlighting a sleeping giant with their...

Continue Reading
Genedata's New ELN Transforms Biopharma R&D Workflows

Updated Category News Views 58

Revolutionizing Research with a New Digital Tool Genedata, the brain behind enterprise software for drug discovery, has thrown a curveball into the world of biopharmaceutical research by launching a pioneering electronic lab notebook (ELN). This isn’t just another software update; it's a complete shift in how R&D workflows are structured and maintained. With an...

Continue Reading
Hollywood Vampires' Limited Art Sparks Las Vegas Buzz

Updated Category News Views 80

A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...

Continue Reading
Samuel Oschin Air & Space Center Takes Flight This Fall

Updated Category News Views 73

The Grand Unveiling: November Highlights Look at this: space nerds, dreamers, and just about anybody with a heartbeat and a sense of wonder should circle November 13, 2026, like a kid with a candy store gift card. That's when the California Science Center throws open the doors to the Samuel Oschin Air and Space Center. You might as well slap a 'world's first' sticker on...

Continue Reading
Palmdale Propane Expands with Affordable Gas Buy

Updated Category News Views 50

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 147

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 73

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women in HVACR: Join the 2025 Convention

Updated Category News Views 247

Women in HVACR Announces Annual Convention The nonprofit organization is now accepting registrations for an upcoming conference aimed at empowering women in the HVACR industry. Details About the Conference Women in HVACR (WHVACR) has confirmed that it will host its annual conference at the Red Rock Casino, Resort & Spa. Registration is currently open, inviting...

Continue Reading
Exploring Growth in the Global Personalized Gifts Industry

Updated Category News Views 191

Overview of the Personalized Gifts Market In today's world, the personalized gifts market is on the verge of a significant expansion, projected to increase by USD 10.76 billion by 2029. This remarkable growth results from various factors, including advancements in technology and changing consumer preferences. More than ever, people value unique and heartwarming gifts that...

Continue Reading
Cellectar Biosciences Sees Growth Amid Drug Development Advances

Updated Category News Views 252

Cellectar Biosciences Financial Performance and Recent Developments Cellectar Biosciences, Inc. (NASDAQ: CLRB), a biopharmaceutical company dedicated to cancer treatment, has announced its financial results for the year ending December 31, 2024. As it advances towards new treatment protocols and expands into clinical trials, the firm reveals a positive outlook for growth....

Continue Reading
Fair Play Menarini: Celebrating 30 Years in Florence

Updated Category News Views 11

Honoring Athletes with Integrity In this fast-paced world of competitive sports, it's easy to get lost in the glitz and glamour, the medals, the money, the fame—heck, even the scandals. Yet, there's an award out there tipping its hat to those who've kept their heads straight and their hearts clean, come hell or high water. We had ourselves a real humdinger of a night in...

Continue Reading
Vidu Unveils Innovative AI Technology to Transform Photography

Updated Category News Views 350

Vidu Revamps the Photography Landscape with AI Innovation ShengShu Technology presents Vidu's groundbreaking Reference-to-Image feature, primed to transform our understanding of photography. This innovative image compositing tool offers a unique capability to generate lifelike photographs from a collection of seven reference images, while ensuring the utmost consistency...

Continue Reading
reckenridge Launches Everolimus Tablets to Enhance Patient Care"> Continue Reading